MarketFoolery

Tesla, Teva, and the Danger of Debt

MarketFoolery

Tesla shares rise on strong 2nd-quarter profits, but the company still needs cash.  Bill Mann analyzes Tesla’s short-term future and why Elon Musk continues to set ambitious production targets.  Teva Pharmaceuticals sinks to a 13-year low on a bad 2nd-quarter report combined with slashing the dividend.  Plus, Bill shares observations, both business and personal, from his recent trip to Africa. Thanks to Bombfell for supporting The Motley Fool.  Get $25 off your first purchase at http://bombfell.com/fool

Next Episodes

MarketFoolery

A Very Apple Christmas @ MarketFoolery

📆 2017-08-02 20:27 / 00:34:21


MarketFoolery

Tasty Earnings @ MarketFoolery

📆 2017-08-01 18:59 / 00:15:02


MarketFoolery

“They have no room for error.” @ MarketFoolery

📆 2017-07-31 18:18 / 00:21:25


MarketFoolery

Facebook’s Big Surprise @ MarketFoolery

📆 2017-07-27 20:30 / 00:20:43


MarketFoolery

Boeing Soars, Chipotle Struggles @ MarketFoolery

📆 2017-07-26 20:57 / 00:30:09